Dynamics of nanoparticles using a new isolated lymphatic
vessel lumen perfusion system

19th February 2021by admin0

Nanoparticles used in drug delivery systems,
bioimaging, and regenerative medicine migrate from tissues to
lymphatic vessels after entering the body, so it is necessary to
clarify the interaction between nanoparticles and lymphatic
vessels. Although technology to observe the flow of nanoparticles
through lymphatic vessels in vivo has been developed, there has
been no method to evaluate the flow of nanoparticles in a more
detailed and quantitative manner ex vivo. Thus, research was
conducted to develop an ex vivo lymphatic vessel lumen perfusion
system to determine how nanoparticles move in lymphatic vessels and
how they affect the physiological movement of lymphatic
vessels.

Leave a Reply

Your email address will not be published. Required fields are marked *

https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
Subscribe

If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

    New Fusion

    The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

    Subscribe

    If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

      New Fusion

      The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

      Copyright ©2024 New Fusion All Rights Reserved

      Designed by FallingBrick